SCHEMBL30906985

SCHEMBL30906985

CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CC[C@H](O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.88
MMP2 P08253 3/20 0.88
HTR2B P41595 2/20 0.88
MEN1 O00255 10/20 0.79
KMT2A Q03164 10/20 0.79
MAPT P10636 6/20 0.79
RECQL P46063 6/20 0.79
SMN1; SMN2 Q16637 4/20 0.79
USP2 O75604 3/20 0.79
TP53 P04637 3/20 0.79
CYP3A4 P08684 3/20 0.79
HBB P68871 2/20 0.79
THRB P10828 8/20 0.70
BLM P54132 8/20 0.70
KDM4E B2RXH2 4/20 0.70
CASP1 P29466 2/20 0.70
HSD17B10 Q99714 2/20 0.70
FNTA P49354 1/20 0.68
FNTB P49356 1/20 0.68
MAPK1 P28482 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29561695 1.00 PTGS1 (0.88) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL29885566 0.95 MMP2 (0.80) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL31507009 0.94 PTGS1 (0.86) PTGS1MMP2HTR2BMEN1KMT2A
SCHEMBL31507008 0.94 MEN1 (0.79) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL10079204 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL10061856 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL6255351 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL10201119 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL31238004 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A
Aclarubicin SCHEMBL31277372 0.94 PTGS1 (1.00) PTGS1MMP2HTR2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250027882-A1 POLYMER DYE FOR DETECTING HYDROGEN PEROXIDE AND HYDROGEN PEROXIDE DETECTING MATERIAL CANON KK (JP) 2025-01-23 US disclosed
US-12140549-B2 Polymer dye for detecting hydrogen peroxide and structure for detecting hydrogen peroxide CANON KABUSHIKI KAISHA (JP) 2024-11-12 US disclosed
WO-2024097730-A2 SENSOR STABILITY GLUCOVATION, INC. (US) 2024-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12140549-B2 Polymer dye for detecting hydrogen peroxide and structure for detecting hydrogen peroxide MPO, GPX4, LPO PTGS1 541/4885MMP2 166/4885HTR2B 3005/4885
US-20250027882-A1 POLYMER DYE FOR DETECTING HYDROGEN PEROXIDE AND HYDROGEN PEROXIDE DETECTING MATERIAL MPO, GPX4, LPO PTGS1 855/4885MMP2 106/4885HTR2B 1599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.